Moxyplit CV 228.5 Plus Dry Syrup contains Amoxycillin 200mg and Clavulanic Acid 28.5mg, a broad-spectrum beta-lactam antibiotic combination. It is highly effective in treating bacterial infections caused by susceptible organisms, including beta-lactamase producing strains.
Amoxycillin works by inhibiting bacterial cell wall synthesis, leading to bacterial cell death, while Clavulanic Acid prevents enzymatic degradation of Amoxycillin, enhancing its spectrum of activity. This combination ensures effective treatment of resistant bacterial infections.
Clinically, Moxyplit CV 228.5 Plus Dry Syrup is indicated for respiratory tract infections, urinary tract infections, skin and soft tissue infections, otitis media, and pediatric infections. The dry syrup formulation allows accurate dosing, easy administration for children, and convenient reconstitution.
Regular use under medical supervision helps in rapid resolution of infection, prevention of complications, and improved patient outcomes. Moxyplit CV 228.5 Plus Dry Syrup is a trusted pediatric and broad-spectrum antibiotic therapy, offering efficacy, safety, and convenience in managing bacterial infections.